Transforming growth factor-beta signaling and ubiquitinators in cancer.
about
Animal HECT ubiquitin ligases: evolution and functional implications.The ubiquitin-proteasome system and assays to determine responses to inhibitors.Ubiquitination-dependent regulation of signaling receptors in cancer.Fucoidan inhibition of lung cancer in vivo and in vitro : role of the Smurf2-dependent ubiquitin proteasome pathway in TGFβ receptor degradationBlocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signalingThe role of cytokines in breast cancer development and progressionTherapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats.Targeting Transforming Growth Factor-Beta1 (TGF-β1) Inhibits Tumorigenesis of Anaplastic Thyroid Carcinoma Cells Through ERK1/2-NFκkB-PUMA Signaling.In search of adrenocortical stem and progenitor cellsRegulating the stability of TGFbeta receptors and Smads.Degradation of activated protein kinases by ubiquitination.Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.The role of ubiquitin-proteasome system in glioma survival and growth.The emerging roles of deubiquitylating enzymes (DUBs) in the TGFβ and BMP pathways.Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.Expression of nodal and nodal receptors in prostate stem cells and prostate cancer cells: autocrine effects on cell proliferation and migration.Recent advances in understanding of interactions between genes and diet in the etiology of colorectal cancer.Structural and biophysical insights into the ligand-free Pitx2 homeodomain and a ring dermoid of the cornea inducing homeodomain mutant.microRNA-193a stimulates pancreatic cancer cell repopulation and metastasis through modulating TGF-β2/TGF-βRIII signalings.Ubiquitination and regulation of Smad7 in the TGF-β1/Smad signaling of aristolochic acid nephropathy.
P2860
Q33533462-159BEBE1-6E8B-4DED-9512-6199DFD02FEBQ34347848-FFC2DC62-B665-4973-92AC-FA4C0E192EDAQ34365210-C6A24B76-54D0-4428-9A69-6008EF08A06AQ34365917-5B10A05C-89AB-427C-8843-6337B03A433BQ34559028-6BEBA546-E376-42CE-BC1F-9E499D6A0BC1Q34920381-9D4BD8CB-EB77-4296-9199-5900230059B2Q35903165-2C45B8F8-92FD-483C-953B-A284760BC089Q37066695-FD19258D-28CC-4820-B6F8-212006D89C8FQ37305066-76730D65-BCB0-4EC1-8138-4FDC85AEA5F7Q37333694-B314F9F1-B7A1-4C05-BE0A-98C22BFEF517Q37419861-E905FCBE-69C4-4588-B719-F27595F2F5A1Q37918451-5CA988E0-A9FC-4219-86DE-707B71BAFBEFQ38107999-10C06B48-A15E-42E1-BCB8-B8FA4DF5969EQ38227721-7894937B-2313-4D7E-8B98-FFF0B45D2D56Q38894640-8E23A5B0-156B-4731-9FE7-3D2B227D99C0Q39218826-57E303EA-768B-4670-83F1-FB1B4CEABF21Q39545341-28D9F729-08C9-444F-A71D-67692BAC3D9DQ39805164-F905E2E4-FF3F-4466-BA2D-C02E8BC3FC36Q40616206-D52618FB-D53A-4428-9766-F95048796AC4Q50046512-F2125788-FB79-435F-ACE5-C65818BE8D11Q53455147-92D67018-B5C6-46D7-9481-53F6A2180570
P2860
Transforming growth factor-beta signaling and ubiquitinators in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@en
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@nl
type
label
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@en
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@nl
prefLabel
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@en
Transforming growth factor-beta signaling and ubiquitinators in cancer.
@nl
P2860
P356
P1476
Transforming growth factor-beta signaling and ubiquitinators in cancer
@en
P2093
Lopa Mishra
P2860
P356
10.1677/ERC-07-0168
P50
P577
2008-03-01T00:00:00Z